The University of Chicago Phase II Consortium (UC P2C) is a collaborative academic/community partnership funded by the National Cancer Institute to conduct early phase oncology clinical trials.
For more information about the UC P2C, click here.
For lists of UC P2C Institutional Members and Contacts, click here.
For Patients, click here.
Studies: Protocols, Consent Forms, Brochures, Schemas
Forms: Case Report Forms, Pharmacy, Financial, LOI and Protocol Templates
Reports: Accrual, AdEERS and Safety Reports
Education: Policies and Procedures, Symposia Presentations